Development of patient-derived xenograft (PDX) models for pancreatic carcinoma as a preclinical platform for drug development

被引：0
|
作者：
Ricono, Jill
Thatte, Jayant
Scott, Colleen
Broudy, Thomas B.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5185
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
    Mercatali, Laura
    La Manna, Federico
    Groenewoud, Arwin
    Casadei, Roberto
    Recine, Federica
    Miserocchi, Giacomo
    Pieri, Federica
    Liverani, Chiara
    Bongiovanni, Alberto
    Spadazzi, Chiara
    de Vita, Alessandro
    van der Pluijm, Gabri
    Giorgini, Andrea
    Biagini, Roberto
    Amadori, Dino
    Ibrahim, Toni
    Snaar-Jagalska, Ewa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08):
  • [42] Patient-derived xenograft (PDX) models, applications and challenges in cancer research
    Shahrokh Abdolahi
    Zeinab Ghazvinian
    Samad Muhammadnejad
    Mahshid Saleh
    Hamid Asadzadeh Aghdaei
    Kaveh Baghaei
    Journal of Translational Medicine, 20
  • [43] Patient-derived xenograft (PDX) models for triple negative breast cancer (TNBC): A pre-clinical platform for drug discovery
    Thatte, Jayant
    Meza, Miguel
    Ricono, Jill
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [44] Establishment of patient-derived xenografts (PDX) models for small cell lung (SCL) as a pre-clinical platform for drug development
    Broudy, T.
    Ricono, J.
    Mullins, C.
    Mirsaidi, C.
    Nair, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 59 - 59
  • [45] Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery
    Zhang, Jingchuan
    Jiang, Dongxian
    Li, Xiaojing
    Lv, Jing
    Xie, Liang
    Zheng, Li
    Gavine, Paul R.
    Hu, Qin
    Shi, Yuan
    Tan, Lijie
    Ge, Di
    Xu, Songtao
    Li, Leon
    Zhu, Lifang
    Hou, Yingyong
    Wang, Qun
    LABORATORY INVESTIGATION, 2014, 94 (08) : 917 - 926
  • [46] PATIENT-DERIVED XENOGRAFT MODELS OF ENDOMETRIAL CANCER: ESTABLISHMENT, VALIDATION AND PRECLINICAL DRUG EVALUATION
    Coenegrachts, L.
    Schrauwen, S.
    Hermans, E.
    Mangelschots, M.
    Garcia-Dios, D.
    Verbist, G.
    Lambrechts, D.
    Amant, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [47] Patient-derived xenografts: a relevant preclinical model for drug development
    Luca Pompili
    Manuela Porru
    Carla Caruso
    Annamaria Biroccio
    Carlo Leonetti
    Journal of Experimental & Clinical Cancer Research, 35
  • [48] Patient-derived xenografts: a relevant preclinical model for drug development
    Pompili, Luca
    Porru, Manuela
    Caruso, Carla
    Biroccio, Annamaria
    Leonetti, Carlo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [49] Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
    Gao, Jing
    Lan, Jianqiang
    Liao, Haiyan
    Yang, Fang
    Qiu, Pei
    Jin, Feng
    Wang, Shubin
    Shen, Lin
    Chao, Tengfei
    Zhang, Cheng
    Zhu, Yu
    BMC CANCER, 2023, 23 (01)
  • [50] Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
    Jing Gao
    Jianqiang Lan
    Haiyan Liao
    Fang Yang
    Pei Qiu
    Feng Jin
    Shubin Wang
    Lin Shen
    Tengfei Chao
    Cheng Zhang
    Yu Zhu
    BMC Cancer, 23
12345